Estimating the cost impact of including Magnetic Resonance Imaging (MRI) in the National Health Service Breast Screening Programme (NHSBSP) for population-risk women in England Professor Claire Hulme, University of Exeter

Professor Claire Hulme is a health economist and Director of the Institute of Health Research in the College of Medicine and Health at the University of Exeter. With over 150 published papers and in excess of £30 million funding over her career, her background and interests lie in complex interventions (specifically those which span the health and social care sectors). Her portfolio of research and expertise spans disease areas but with particular focus on oncology and on older people. Her research includes a wide range of methodologies including economic evaluation, large data analysis and use of qualitative methods in health economics. As an expert in health economics, Claire sits on a number of national committees which currently includes the NIHR Methods Incubator, NIHR Research for Social Care Programme, NIHR Programme Grants for Applied Health Research Programme. Nationally she also sits on the MS Register Executive Committee.

Expression of the gadolinium transporters SLCO1B1 and SLCO1B3 in breast cancers: A potential role in influencing tumour enhancement on MRI Rachel Sutherland, Newcastle University

Rachel Sutherland is a final year PhD student at Newcastle University where she is investigating the expression and function of solute carrier transporters in different types of breast cancer and breast cancer stem cells. She previously gained her undergraduate degree in biomedical sciences from the University of Hull and her master’s degree in cardiovascular sciences in health and disease from Newcastle University.

Determination of onset fatigue while reading Digital Breast Tomosynthesis (DBT) cases – Mitchell Searjeant, University of Nottingham

Mitchell Searjeant is a Research Technician for the Applied Vision Research Centre. After graduating with a First Class Honours from the Department of Physics and Astronomy at the University of Manchester, he quickly joined the Digital Cancer Screening team, applying his extensive experience in the lab and data analysis to a strong focus on all things eye tracking.
Mitchell became a member of the Digital Cancer Screening team in 2020 and has been involved in major quality assurance projects including: PROSPECTS, PERFORMS and Digital Pathology – all relating to breast cancer.